THERAPEUTIC OR PROPHYLACTIC AGENT FOR NOCTURIA

WIPO Patent Application WO/2020/080399

A1

Provided are a pharmaceutical composition, which comprises, as an active ingredient, a potassium citrate and sodium citrate hydrate preparation or a sodium hydrogencarbonate preparation, etc. By administering the pharmaceutical composition according to the present invention, etc., the prevention or treatment of nocturia can be achieved.

WO/2018/193648	BLOOD PURIFICATION THROUGH ALKALIFYING AGENT
JP7012407	Composition for measures against sickness
JP2013006851	CALCIUM PHOSPHATE COMPLEX AND SALT USED FOR ORAL CAVITY TRANSPORT SYSTEM,

ARUGA SEIJI (JP)
NISHIOKA KOICHIRO (JP)
YAMASAKI SATOMI (JP)

PCT/JP2019/040658

April 23, 2020

October 16, 2019

Click for automatic bibliography generation  

NIPPON CHEMIPHAR CO (JP)

A61K31/194; A61K9/20; A61K33/00; A61K45/00; A61P7/12; A61P13/10; A61P13/12

WO2016143200A1	2016-09-15
WO2012001469A1	2012-01-05

JP2011520980A	2011-07-21
JP2007529493A	2007-10-25
JP2018195570A	2018-12-06

UEDA, T. ET AL.: "Urine alkalization improves the problems of pain and sleep in hypersensitive bladder syndrome", INTERNATIONAL JOURNAL OF UROLOGY, vol. 21, 2014, pages 512 - 517, XP055702308
SONMEZ, G. M. ET AL.: "Effects of urine alkalinization with sodium bicarbonate orally on lower urinary tract symptoms in female patients: a pilot study", INTERNATIONAL UROGYNECOLOGICAL JOURNAL, vol. 29, 2017, pages 1029 - 1033, XP036528294, DOI: 10.1007/s00192-017-3492-3
J. UROL., vol. 186, 2011, pages 1358 - 1363
DRUGS AGING, vol. 15, 1999, pages 429 - 437
J. UROL., vol. 190, 2013, pages 965 - 972
See also references of EP 3868370A4

TANAI Sumio et al. (JP)

View/Download PDF      PDF Help

Previous Patent: AGENT FOR SUPPRESSING ALCOHOL SICKNESS OR HANGOVER CAUSED BY ALCOHOLIC BEVERAGE INTAKE

Next Patent: SUPPORTED METAL CATALYST AND METHOD FOR PRODUCING SAME